BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2117257)

  • 1. Negative regulation of human c-fos expression by the retinoblastoma gene product.
    Robbins PD; Horowitz JM; Mulligan RC
    Nature; 1990 Aug; 346(6285):668-71. PubMed ID: 2117257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common set of nuclear factors bind to promoter elements regulated by the retinoblastoma protein.
    Udvadia AJ; Rogers KT; Horowitz JM
    Cell Growth Differ; 1992 Sep; 3(9):597-608. PubMed ID: 1419910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of c-fos induces expression of the retinoblastoma tumor suppressor gene Rb in transfected cells.
    Pai SR; Bird RC
    Anticancer Res; 1994; 14(6B):2501-8. PubMed ID: 7872673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional analysis of the regulatory sequences of the ets-1 gene.
    Oka T; Rairkar A; Chen JH
    Oncogene; 1991 Nov; 6(11):2077-83. PubMed ID: 1945412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL; Rand A; Kelm RJ; Getz MJ
    Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of c-fos promoter by MyoD on muscle cell differentiation.
    Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
    Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the Rb tumor suppressor protein with the c-fos promoter in c-fos transfected cells overexpressing c-fos and Rb.
    Pai SR; Bird RC
    Anticancer Res; 1997; 17(5A):3265-72. PubMed ID: 9413158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription.
    Schönthal A; Büscher M; Angel P; Rahmsdorf HJ; Ponta H; Hattori K; Chiu R; Karin M; Herrlich P
    Oncogene; 1989 May; 4(5):629-36. PubMed ID: 2498806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals.
    Jamal S; Ziff E
    Nature; 1990 Mar; 344(6265):463-6. PubMed ID: 2157161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.
    Lasorella A; Noseda M; Beyna M; Yokota Y; Iavarone A
    Nature; 2000 Oct; 407(6804):592-8. PubMed ID: 11034201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
    Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
    Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
    Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
    Schönthal A; Feramisco JR
    New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoblastoma gene product, Rb, represses neu expression through two regions within the neu regulatory sequence.
    Matin A; Hung MC
    Oncogene; 1994 May; 9(5):1333-9. PubMed ID: 7908732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.